Delivery Order HHSF223201610027I-HHSF22301001T

Award Date 9/20/16
Potential Completion Date 9/29/21
Potential Value $805K
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
NEWTON U F, MA 02464, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Firm Fixed Price delivery order awarded by the Food and Drug Administration (FDA) to Integrated Behavioral Health, Inc., a for-profit subchapter S corporation. The $1,024,971 contract is for data resources and surveillance reports to support post-marketing monitoring of non-medical use of pharmaceuticals and illicit drug use. The contract has a six-month performance period with a completion date of September 29, 2026. This delivery order is part of a larger $10 million FDA indefinite...
The Food and Drug Administration (FDA) awarded a $1,046,568.62 firm-fixed price delivery order to Integrated Behavioral Health, Inc., a for-profit subchapter S corporation, to study the prevalence, experiences, knowledge, and perceptions of falsified and unapproved pharmaceuticals among individuals being assessed for or entering substance use disorder treatment. This delivery order is part of a larger $10 million indefinite delivery contract the FDA has with Integrated Behavioral Health to...
The Department of Health and Human Services Food and Drug Administration (FDA) awarded a Firm Fixed Price Delivery Order contract to Inflexxion, Inc., a for-profit organization, to improve the quality and representativeness of the Addiction Severity Index-Multimedia Version (ASI-MV) Network. This contract, with a potential value of $1,095,103.00, is associated with the FDA Prescription Drug Abuse Summary Reports Master IDIQ contract vehicle. The contract does not have a set-aside designation and...
The Department of Health and Human Services Food and Drug Administration (FDA) awarded a firm fixed price purchase order to Source Healthcare Analytics LLC, a global provider of outsourced development services to the pharmaceutical and medical device industries. The $140,032 contract is for access to prescription and non-retail sales data by geography, to support the FDA's monitoring of drug safety and effectiveness during the national health emergency. This award is associated with a larger $45...
This is a $1,467,579.00 delivery order contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to the Denver Health and Hospital Authority (Denver Health) on September 20, 2019. The contract is titled "IMPROVING THE QUALITY AND REPRESENTATIVENESS OF THE TREATMENT CENTER PROGRAM DATA" and has a completion date of March 15, 2025. The contract is a Firm Fixed Price type with no set-aside designation. It is issued under the FDA...
<p>This is a $359,880.23 firm fixed price definitive contract awarded by the Food and Drug Administration (FDA), a civilian agency, to US Data Management, LLC for a pilot project to support the implementation of the Drug Supply Chain Security Act. The contract does not have a set-aside designation. The contract's ultimate completion date is September 15, 2020. No other details about major subcontractors or the agency's broader programs are provided in the information given.</p>
This is a 2-year, firm fixed price (FFP) type task order awarded to Core Human Factors, Inc. by the Food and Drug Administration (FDA), a civilian agency. The contract is to procure comparative use human factors (CUHF) studies to assess the impact of differences between the user interfaces of a generic drug-device combination product and its reference listed drug. The contract has a ceiling value of $679,960.00 and does not have a set-aside designation. The award date is September 18, 2024,...
This is a firm fixed price delivery order contract awarded by the Department of Health and Human Services' Food and Drug Administration (FDA) to Iqvia Government Solutions Inc., a provider of healthcare data, analytics, and related services. The contract is for access to over-the-counter drug utilization data, with a potential value of $399,769.88 and a completion date of September 27, 2023. Iqvia has provided similar data and analytics services to the FDA, Centers for Disease Control and...
The Department of Health and Human Services, Food and Drug Administration (FDA) awarded a $20,228,255.16 firm fixed price delivery order to Source Healthcare Analytics LLC's SHS Division, a foreign-owned, self-certified small disadvantaged business. The delivery order, issued under a $45 million single-award Indefinite Delivery Contract, provides the FDA access to outpatient prescription and patient-level drug utilization data over a five-year period to support the agency's drug safety...
<p>This is a $41,708.02 firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Morebetter, LTD, a for-profit organization. The contract is for the &quot;RELEAF APP DATA&quot; requirement and has a period of performance through September 29, 2023. The contract does not have a set-aside designation. No additional details about larger contracting vehicles or subcontractors were provided.</p>

This is a Firm Fixed Price delivery order task order awarded by the Food and Drug Administration (FDA) to Inflexxion, Inc. for a "DATA RESOURCE FOR POST-MARKETING PRESCRIPTION AND OVER-THE-COUNTER DRUG ABUSE SURVEILLANCE DATA FROM INDIVIDUALS ENTERING OR BEING ASSESSED FOR SUBSTANCE ABUSE TREATMENT SUMMARY REPORTS." The task order is part of the FDA Prescription Drug Abuse Summary Reports contract vehicle. The award has a ceiling value of $805,497.01 and was made on September 20, 2016, with a completion date of September 29, 2021. This award does not have a set-aside designation.

Generated 4/2/25, 5:53 PM